DISINFO: Western vaccines are developed for financial speculation whereas Russian vaccines are to save lives
SUMMARY
There are two type of Vaccines, the Western ones and the ones of the BRICS, like the Russian ones.
On the one hand, Western vaccines are based on new and unproven technologies. Their communication is orchestrated to favour speculation on the stock exchange. There is a bidding war for vaccines with efficiency of 90%, 92%, 94.8%… But the full results of the tests are not published and if some people die from the vaccine, or for another reason, the tests will have to be stopped or speed down. All of this is opaque and unclear. They progress to make the most profit from speculation.
On the other hand, Russian vaccines, like Sputnik V are base on proven technologies. Russians are totally open concerning the development of the vaccine. Everything is published, there is no shadow zone at all. They progress in a logical way in the interest of the population.
The problem is people don’t trust everything that comes from Russia. Even though we are explained that Russian science can create the best pathogen viruses and neurotoxic agent in the world. Development of a vaccine is exactly the same scientific procedure. So if they have advanced chemical weapons, it is the same with vaccines.
RESPONSE
Disinformation message that tries to cast doubt about the vaccines developed by Western companies.
The fact that Pfizer Chief Executive Albert Bourla sold $5.6m of stock he owned in the company is part of a pre-arranged 10b5-1 plan. Such plans allow executives and other corporate insiders to sell a number of shares within a pre-determined timeframe and price range, so as to avoid allegations of using non-public company information for personal gain.
While Russian vaccine Sputnik V was declared by the pro-Kremlin media to be the first vaccine ever registered in the world, it was announced even before the start of phase 3 of the clinical trials, normally required for any new drug. The Russian association of organisations on clinical trials urged Russia to postpone registration, because it had not even been tested by hundreds of people.
The fact that the Gamaleya National Center of Epidemiology and Microbiology developed the vaccine Sputnik V financed by the Russian Direct Investment Fund (RDIF) rather than from a company listed on a stock exchange doesn't make the development process more transparent or free of political and financial interests. Open media published an investigation in October 2020 about the interest links of the Gamaleya Center and its subsidiaries.
See related stories: Russian coronavirus vaccine has dozens of orders unlike the American one , "Sputnik V" criticism is based on financial motives , The West is waging a war over the COVID-19 Sputnik V vaccine .